John A. Wagner

10.2k total citations · 3 hit papers
130 papers, 7.1k citations indexed

About

John A. Wagner is a scholar working on Mechanical Engineering, Organizational Behavior and Human Resource Management and Mechanics of Materials. According to data from OpenAlex, John A. Wagner has authored 130 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Mechanical Engineering, 18 papers in Organizational Behavior and Human Resource Management and 14 papers in Mechanics of Materials. Recurrent topics in John A. Wagner's work include Aluminum Alloy Microstructure Properties (13 papers), Management and Organizational Studies (11 papers) and Job Satisfaction and Organizational Behavior (9 papers). John A. Wagner is often cited by papers focused on Aluminum Alloy Microstructure Properties (13 papers), Management and Organizational Studies (11 papers) and Job Satisfaction and Organizational Behavior (9 papers). John A. Wagner collaborates with scholars based in United States, Japan and United Kingdom. John A. Wagner's co-authors include Suzanne Crampton, Richard Z. Gooding, John R. Hollenbeck, Michael K. Moch, Marie McKendall, Elena S. Izmailova, Eric Perakslis, J. L. Stimpert, Edwin A. Locke and Regis B. Kelly and has published in prestigious journals such as Academy of Management Review, Academy of Management Journal and Gastroenterology.

In The Last Decade

John A. Wagner

121 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Percept-percept inflation in microorganizational research: An investigation of prevalence and effect.

1994 1.0k citations John A. Wagner et al. profile →
STUDIES OF INDIVIDUALISM-COLLECTIVISM: EFFECTS ON COOPERATION IN GROUPS.

1995 839 citations John A. Wagner profile →
Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement

2006 504 citations Jean W. Lee, Viswanath Devanarayan et al. Pharmaceutical Research profile →

Peers

Countries citing papers authored by John A. Wagner

Since Specialization

Citations

This map shows the geographic impact of John A. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Wagner more than expected).

Fields of papers citing papers by John A. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Wagner. The network helps show where John A. Wagner may publish in the future.

Co-authorship network of co-authors of John A. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Wagner. A scholar is included among the top collaborators of John A. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Wagner. John A. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regulatory Pathways for Qualification and Acceptance of Digital Health Technology‐Derived Clinical Trial Endpoints: Considerations for Sponsors 2024 ·Clinical Pharmacology & Therapeutics ·Jessie P. Bakker, Elena S. Izmailova, (unknown), Steven C. Hoffmann, (unknown), Joseph P. Menetski, John A. Wagner	6
2	Dimensional research on organization structure: meta-analysis and conceptual redirection 2021 ·Journal of Management & Organization ·John A. Wagner	3
3	What evidence do we need for biomarker qualification? 2017 ·Science Translational Medicine ·(unknown), Joseph P. Menetski, John A. Wagner, (unknown), Linda S. Brady, (unknown), William W. Chin, (unknown), Gary J. Kelloff, Gabriela Lavezzari, Rajesh Ranganathan, John‐Michael Sauer, Frank D. Sistare, Tanja S. Zabka, David Wholley	45
4	A dynamic map for learning, communicating, navigating and improving therapeutic development 2017 ·Nature Reviews Drug Discovery ·John A. Wagner, Andrew M. Dahlem, Lynn D. Hudson, Sharon F. Terry, Russ B. Altman, (unknown), (unknown), Christopher P. Austin	40
5	Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease 2015 ·Respiratory Medicine ·Hong Sun, John Palcza, Russell Rosenberg, Meir H. Kryger, (unknown), Janice Rowe, Christopher Lines, John A. Wagner, Matthew D. Troyer	37
6	Effects of the orexin receptor antagonist suvorexant on respiration during sleep in healthy subjects 2015 ·The Journal of Clinical Pharmacology ·Naoto Uemura, Jacqueline B. McCrea, Hong Sun, (unknown), Gary Zammit, Rong Liu, (unknown), (unknown), Christopher Lines, Matthew D. Troyer, John A. Wagner	26
7	Psychometrics of the Personal Questionnaire: A client-generated outcome measure. 2015 ·Psychological Assessment ·Robert Elliott, John A. Wagner, Célia M. D. Sales, Brian Rodgers, Paula Alves, (unknown)	76
8	Readings in organizational behavior 2010 ·Routledge eBooks ·John A. Wagner, John R. Hollenbeck	8
9	PhRMA Survey on the Conduct of First‐in‐Human Clinical Trials Under Exploratory Investigational New Drug Applications 2010 ·The Journal of Clinical Pharmacology ·Adel H. Karara, Timi Edeki, James F. McLeod, Alfred Tonelli, John A. Wagner	10
10	Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women 2010 ·British Journal of Clinical Pharmacology ·Matt S. Anderson, William D. Hanley, (unknown), Bo Jin, Frederick A. Bieberdorf, James Kost, Larissa Wenning, Julie A. Stone, John A. Wagner, Marian Iwamoto	18
11	EBSD Study of Delamination Fracture in Al–Li Alloy 2090 2008 ·Experimental Mechanics ·Wesley A. Tayon, R. Crooks, Marcia S. Domack, John A. Wagner, A.A. Elmustafa	42
12	Microtexture and nanoindentation study of delamination cracking in Al-Cu-Li-X alloys 2006 ·WIT transactions on the built environment ·R. Crooks, Marcia S. Domack, John A. Wagner	4
13	Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement breakdown → 2006 ·Pharmaceutical Research ·Jean W. Lee, Viswanath Devanarayan, Yu Chen Barrett, Russell Weiner, John Allinson, Scott Fountain, Stephen Keller, Ira Weinryb, Marie Green, (unknown), James A. Rogers, Robert Millham, Peter J. O’Brien, (unknown), Masood N. Khan, Chad Ray, John A. Wagner	504
14	A cost-effectiveness approach to the qualification and acceptance of biomarkers 2006 ·Nature Reviews Drug Discovery ·Stephen A. Williams, (unknown), John A. Wagner, Chris Webster	40
15	Method Validation and Measurement of Biomarkers in Nonclinical and Clinical Samples in Drug Development: A Conference Report 2005 ·Pharmaceutical Research ·Jean W. Lee, (unknown), (unknown), Ronald R. Bowsher, Dean W. Knuth, Peter J. O’Brien, Jean L. Fourcroy, Rakesh Dixit, Lini Pandite, Robert G. Pietrusko, Holly Soares, Valerie Quarmby, O. Vesterqvist, David M. Potter, (unknown), (unknown), Timothy J. O’Leary, Lorah Perlee, Sunil Kadam, John A. Wagner	125
16	Pituitary adenylate cyclase‐activating polypeptide inhibits cutaneous immune function 2003 ·European Journal of Immunology ·(unknown), (unknown), Wanhong Ding, Kristina Seiffert, John A. Wagner, Richard D. Granstein	18
17	CATHODIC PROTECTION DEVELOPMENTS FOR PRESTRESSED CONCRETE COMPONENTS. INTERIM REPORT 1993 ·John A. Wagner, (unknown), (unknown), (unknown)	1
18	CATHODIC PROTECTION OF PRESTRESSED MEMBERS: AN UPDATE 1991 ·Transportation Research Record Journal of the Transportation Research Board ·John A. Wagner, (unknown), (unknown)	4
19	The Organizing Dilemma: Individualism, Collectivism, and the Control of Organization 1982 ·University Microfilms International eBooks ·John A. Wagner	2
20	Studies on the maturation of the head of bacteriophage T4 1976 ·Philosophical transactions of the Royal Society of London. Series B, Biological sciences ·John A. Wagner, Ulrich K. Laemmli	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact